AlphaFold vs Homology Modeling: When to Use Each
AlphaFold didn’t make homology modeling obsolete — it made the choice between them more nuanced. Understanding when each method is genuinely better leads to better structures, fewer wasted experiments, and more defensible methods sections.
How they differ fundamentally
The difference between AlphaFold and homology modeling is not just technical — it’s a difference in what information each method uses to make its prediction, and therefore in what each method is capable of.
AlphaFold2 / AF3
Learns from evolution
Information source
Patterns in millions of protein sequences — co-evolutionary signals extracted from multiple sequence alignments
Template requirement
None — predicts from sequence alone (though uses MSA for evolutionary information)
Output
Single predicted structure + per-residue confidence (pLDDT) + domain confidence (PAE)
Conformation
Typically predicts the most common / lowest-energy state — usually the apo conformation
Homology modeling
Copies from a template
Information source
The 3D coordinates of an experimentally determined structure of a related protein
Template requirement
Requires a structurally characterized homolog — quality scales with sequence identity
Output
3D model in the conformation of the chosen template, with energy-based quality scores
Conformation
Inherits the template conformation — active, inhibitor-bound, or any other crystallized state
This fundamental difference — sequence-derived vs template-derived conformation — is the key to understanding when each method is appropriate. AlphaFold predicts what it thinks the protein looks like in its most stable state, based on what evolution suggests. Homology modeling produces what the template looks like, adapted for your target sequence.
When AlphaFold is the better choice
-
No structural template exists in the PDBHomology modeling requires a template. If no protein with detectable sequence similarity has a crystal structure, there is nothing to model from. AlphaFold2 has no such requirement — it predicts from sequence and evolutionary data alone, making it the only computational option for genuinely novel proteins.AlphaFold
-
Sequence identity to any known structure is below 30%Below 30% identity, the quality of homology models degrades sharply — the template alignment is unreliable, and modeled loops diverge badly from the true structure. AlphaFold2, which doesn’t depend on a single template but learns from millions of evolutionary relationships, consistently outperforms homology modeling in this identity range.AlphaFold
-
Speed and scale — predicting many proteinsThe AlphaFold Database has pre-computed structures for over 200 million proteins — instant download, no compute required. For novel sequences at scale, ColabFold processes a protein in 15–30 minutes. Homology modeling at scale requires template finding and model building for each sequence individually.AlphaFold
-
You need per-residue confidence scoresAlphaFold provides pLDDT and PAE — quantitative, per-residue confidence that tells you exactly which parts of the prediction to trust. Homology modeling gives you DOPE and QMEAN which are global or residue-level energy metrics, but not the same kind of calibrated confidence the downstream tools increasingly expect.AlphaFold
When homology modeling is still preferred
-
You need a specific functional conformationAlphaFold predicts its best estimate of the dominant ground state — typically the apo (unbound) form. Many drug targets undergo significant conformational change upon ligand binding, between active and inactive states, or when switching between open and closed forms. If a homolog crystallized in the conformation you need exists in the PDB, homology modeling using that template gives you exactly that conformation. AlphaFold fundamentally cannot do this.Homology
-
Modeling a mutant using a wild-type structureWhen you want to understand the structural consequences of a specific mutation — particularly one in a well-characterized protein where an experimental structure exists — homology modeling with the mutant sequence threaded onto the wild-type crystal structure is the most direct and controlled approach. You can compare the mutant model to the experimental wild-type structure residue by residue.Homology
-
High-identity template in a ligand-bound state (>50% identity)If a close homolog has been crystallized in complex with a chemically similar ligand — giving you both a high-quality backbone and a binding-site geometry shaped by that ligand — homology modeling from that template produces a more relevant starting structure for docking or MD than an AlphaFold apo model. The experimental template carries conformational information that sequence-derived prediction cannot access.Homology
-
Consistency with prior literature using homology modelsIn a field where previous computational studies used homology modeling from specific templates, switching to AlphaFold introduces an additional confounding variable when comparing results. If you’re directly extending or replicating prior work, using the same modeling approach makes comparisons cleaner and reviewers less likely to ask why you changed methods.Homology
The most important case: conformation matters
In computational drug discovery, the binding site conformation is everything. An AlphaFold model in the apo state may show a collapsed or occluded binding site that doesn’t reflect the protein’s druggable conformation. If a homolog crystallized in the active or inhibitor-bound state exists with high sequence identity, that template is more valuable than AlphaFold’s best prediction — because it captures the relevant geometry directly from experiment.
Cases where both methods struggle
Intrinsically disordered proteins
Proteins that lack a stable 3D structure in solution — IDPs and IDRs — cannot be meaningfully modeled by either method. AlphaFold correctly reports low pLDDT; homology modeling has nothing to copy.
NMR ensemble or computational IDP methods
Large conformational changes
Proteins that undergo major structural rearrangements (e.g. kinesin during the power stroke, large-scale domain reconfigurations) cannot be captured in a single static model. Both methods predict one state.
Molecular dynamics simulation or cryo-EM ensemble
Membrane proteins without good templates
Membrane proteins are underrepresented in the PDB and structurally diverse. AlphaFold performs reasonably well for transmembrane regions but poorly for extramembrane loops. Homology modeling requires templates that often don’t exist.
AF3 + MD in explicit membrane, or cryo-EM
Very long proteins with multiple domains
Inter-domain arrangements can be wrong in both methods — AlphaFold shows high inter-domain PAE; homology models may inherit template domain arrangements that don’t apply to the target.
Check PAE carefully; use small-angle X-ray scattering for validation
The practical decision framework
Decision framework — start here
1. Is your protein in the AlphaFold Database?
Yes
Download it. Check pLDDT and PAE. Use it unless you need a specific conformation (see Q3).
No
Continue to question 2.
2. Does a structural template exist with >30% sequence identity?
No template
Use AlphaFold2 via ColabFold. No template-based method is viable.
Yes, template exists
Continue to question 3 — both methods are viable, choice depends on what you need.
3. Do you need a specific functional conformation?
No — apo/ground state is fine
Use AlphaFold2. Better accuracy at low sequence identity; confidence scores; faster.
Yes — active/bound/mutant
Use homology modeling. Select a template in the target conformation. AlphaFold cannot replicate this.
4. Template exists and conformation doesn’t matter — which has higher accuracy?
Identity <50%
AlphaFold2 generally outperforms homology modeling at lower sequence identities. Use AlphaFold.
Identity >50%
Both are excellent. Use homology modeling if you want template control; use AlphaFold for confidence scores. Run both and compare.
When in doubt — run both and compare
For important structural questions, running AlphaFold and building a homology model from the best available template is cheap in compute time and rich in information. Agreement between the two methods on the conformation of a key binding site is strong evidence that the conformation is correct. Disagreement is a signal to investigate further — one method may be capturing something biologically meaningful that the other missed.
The one-paragraph verdict
Use AlphaFold by default — it’s faster, requires no template, provides calibrated confidence scores, and generally achieves higher accuracy than homology modeling below 50% sequence identity. Use homology modeling when conformation is the critical variable: when a high-identity template exists in a biologically relevant state (active, inhibitor-bound, specific mutant) that AlphaFold’s sequence-derived prediction cannot replicate. The two methods are complementary, not competing — the researchers getting the best structural models in 2026 use both, for different reasons, at different stages of their projects.